drugset / Trial / NCT02047656
To Evaluate Pharmacokinetics of LFF269 in Healthy Volunteers and Patients With Hypertension
RandomizedParallel-groupDouble-blindTreatment
Summary
This study is designed to enable optimal dose selection of LFF269 for potential future studies by providing additional information about the compounds safety, tolerability, pharmacokinetic and pharmacodynamic profiles.
Timeline
- Start
- 2013-08
- Primary completion
- 2014-08
- Completion
- 2014-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LFF269 | Unknown | — | — |
Indications
No indication recorded.